Billionaire philanthropist goes after drug prices

John Arnold, a former Enron Corp. trader,  donated $500,000 to a newly formed group called Patients for Affordable Drugs, whose main policy goal is lowering U.S. drug prices. The organization advocates giving Medicare, the government program for the elderly, the ability to negotiate drug prices directly with manufacturers—something Big Pharma has long opposed and dreaded.